Previous 10 | Next 10 |
Pacira BioSciences (NASDAQ: PCRX) isn't a shooting star, but the company has been steadily increasing revenue and was profitable in 2020 for only the second time since its initial public offering (IPO) in 2011. The company specializes in developing presurgical and postsurgical non-o...
Ionis Pharmaceuticals ([[IONS]] -22.5%) has lost almost a fifth after announcing that the partner Roche Holding ([[RHHBY]] -3.3%) has discontinued the dosing in the Phase III GENERATION HD1 study for Tominersen in manifest Huntington's disease (“HD”).An investigational...
The FDA has approved Pacira BioSciences' (PCRX) supplemental new drug application (sNDA) seeking expansion of the Exparel label to include use in patients 6 years of age and older for single-dose infiltration to produce postsurgical local analgesia. The sNDA was based on the positive data fro...
-- EXPAREL is the first and only FDA-approved long-acting local analgesic for children aged six and over – -- Conference call tomorrow at 8:30 a.m. ET -- PARSIPPANY, N.J., March 22, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report.Weeke...
-- EXPAREL average daily sales at 103% of the prior year for the month of February 2021 -- PARSIPPANY, N.J., March 09, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions,...
John Paulson’s 13F portfolio value increased from $3.21B to $3.85B this quarter. Paulson & Company's largest three positions are Horizon Therapeutics, Bausch Health, and BrightSphere Investment Group. The stake in Barrick Gold was more than doubled during the quarter. ...
PARSIPPANY, N.J., March 03, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 2021 Barclays Global Healthcare Conference at 10:55 AM ET on Tuesday, March 9, 2021. Live audio of the virtual event can be accessed by visiting the &...
Image source: The Motley Fool. Pacira BioSciences, Inc. (NASDAQ: PCRX) Q4 2020 Earnings Call Feb 25, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Pacira BioSciences, Inc. (PCRX) Q4 2020 Earnings Call Transcript ...
Pacira BioSciences, Inc. (PCRX) Q4 2020 Earnings Conference Call February 25, 2021 08:30 ET Company Participants Susan Mesco - Head of Investor Relations David Stack - Chairman & Chief Executive Officer Charlie Reinhart - Chief Financial Officer Ron Ellis - Senior Vice President Conferenc...
News, Short Squeeze, Breakout and More Instantly...
Pacira BioSciences Inc. Company Name:
PCRX Stock Symbol:
NASDAQ Market:
Pacira BioSciences Inc. Website:
TAMPA, Fla., July 23, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its second quarter financial results after the close of the U.S. markets on Tuesday July 30, 2024. Following the release, the company will host a live conference call and webc...
-- Proposed Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment System Rule extends separate payment from ambulatory surgical centers to include the hospital outpatient environment – -- Rule implements the NOPAIN Act, signed into law as part of the Cons...
A look at the top 10 most actives in the United States Ocean Power Technologies Inc. (OPTT) rose 86.1% to $0.514 on volume of 587,366,807 shares NVIDIA Corporation (NVDA) fell 1.3% to $122.67 on volume of 214,038,378 shares Tesla Inc. (TSLA) rose 10.2% to $231.26 on volume of 201,850,947 ...